Tuesday, April 19, 2011

Biotech Synergy Acquires Multi-Epitope NSCLC Cancer Vaccine Phase 2 Positive Assets And Related Patents

Biotech Synergy Acquires Multi-Epitope NSCLC Cancer Vaccine Phase 2 Positive Assets And Related Patents

No comments:

Post a Comment